Literature DB >> 35975996

Herpes Simplex Virus Type 1 Preferentially Enhances Neuro-Inflammation and Senescence in Brainstem of Female Mice.

Mahesh Kumar Sivasubramanian1, Raisa Monteiro1, Kelly S Harrison2, Bhuvana Plakkot1, Madhan Subramanian1, Clinton Jones2.   

Abstract

Following acute infection, herpes simplex virus 1 (HSV-1) establishes lifelong latency in neurons. The latency associated transcript (LAT) is the only viral gene abundantly expressed during latency. Wild-type (WT) HSV-1 reactivates more efficiently than LAT mutants because LAT promotes establishment and maintenance of latency. While sensory neurons in trigeminal ganglia (TG) are important sites for latency, brainstem is also a site for latency and reactivation from latency. The principal sensory nucleus of the spinal trigeminal tract (Pr5) likely harbors latent HSV-1 because it receives afferent inputs from TG. The locus coeruleus (LC), an adjacent brainstem region, sends axonal projections to cortical structures and is indirectly linked to Pr5. Senescent cells accumulate in the nervous system during aging and accelerate neurodegenerative processes. Generally senescent cells undergo irreversible cell cycle arrest and produce inflammatory cytokines and chemokines. Based on these observations, we hypothesized HSV-1 influences senescence and inflammation in Pr5 and LC of latently infected mice. This hypothesis was tested using a mouse model of infection. Strikingly, female but not age-matched male mice latently infected with a LAT null mutant (dLAT2903) exhibited significantly higher levels of senescence markers and inflammation in LC, including cell cycle inhibitor p16, NLRP3 (NOD-, LRR- and pyrin domain-containing protein 3), IL-1α, and IL-β. Conversely, Pr5 in female but not male mice latently infected with WT HSV-1 or dLAT2903 exhibited enhanced expression of important inflammatory markers. The predilection of HSV-1 to induce senescence and inflammation in key brainstem regions of female mice infers that enhanced neurodegeneration occurs. IMPORTANCE HSV-1 (herpes simplex virus 1), an important human pathogen, establishes lifelong latency in neurons in trigeminal ganglia and the central nervous system. In contrast to productive infection, the only viral transcript abundantly expressed in latently infected neurons is the latency associated transcript (LAT). The brainstem, including principal sensory nucleus of the spinal trigeminal tract (Pr5) and locus coeruleus (LC), may expedite HSV-1 spread from trigeminal ganglia to the brain. Enhanced senescence and expression of key inflammatory markers were detected in LC of female mice latently infected with a LAT null mutant (dLAT2903) relative to age-matched male or female mice latently infected with wild-type HSV-1. Conversely, wild-type HSV-1 and dLAT2903 induced higher levels of senescence and inflammatory markers in Pr5 of latently infected female mice. In summary, enhanced inflammation and senescence in LC and Pr5 of female mice latently infected with HSV-1 are predicted to accelerate neurodegeneration.

Entities:  

Keywords:  HSV-1; LAT; brainstem; immune senescence; inflammation; latency

Mesh:

Year:  2022        PMID: 35975996      PMCID: PMC9472638          DOI: 10.1128/jvi.01081-22

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  81 in total

1.  Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome.

Authors:  John M Busillo; Kathleen M Azzam; John A Cidlowski
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

Review 2.  Antiinflammatory action of glucocorticoids--new mechanisms for old drugs.

Authors:  Turk Rhen; John A Cidlowski
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

3.  Herpes simplex virus DNA sequences in the CNS of latently infected mice.

Authors:  C V Cabrera; C Wohlenberg; H Openshaw; M Rey-Mendez; A Puga; A L Notkins
Journal:  Nature       Date:  1980-11-20       Impact factor: 49.962

4.  Herpes simplex virus type 1 infection and glucocorticoid treatment regulate viral yield, glucocorticoid receptor and NF-kappaB levels.

Authors:  A C Erlandsson; L-G Bladh; P Stierna; T Yucel-Lindberg; O Hammarsten; T Modéer; J Harmenberg; A-C Wikström
Journal:  J Endocrinol       Date:  2002-10       Impact factor: 4.286

5.  Three herpes simplex virus type 1 latency-associated transcript mutants with distinct and asymmetric effects on virulence in mice compared with rabbits.

Authors:  G C Perng; D Esmaili; S M Slanina; A Yukht; H Ghiasi; N Osorio; K R Mott; B Maguen; L Jin; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  In vivo upregulation of endogenous NGF in the rat brain by the alpha2-adrenoreceptor antagonist dexefaroxan: potential role in the protection of the basalocortical cholinergic system during neurodegeneration.

Authors:  Thomas Debeir; M Marien; J Ferrario; P Rizk; A Prigent; F Colpaert; R Raisman-Vozari
Journal:  Exp Neurol       Date:  2004-12       Impact factor: 5.330

Review 7.  Cellular senescence and tumor suppressor gene p16.

Authors:  Hani Rayess; Marilene B Wang; Eri S Srivatsan
Journal:  Int J Cancer       Date:  2011-12-05       Impact factor: 7.396

8.  Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

Authors:  Y Yin; M A Tainsky; F Z Bischoff; L C Strong; G M Wahl
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

9.  MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs.

Authors:  Jennifer Lin Umbach; Martha F Kramer; Igor Jurak; Heather W Karnowski; Donald M Coen; Bryan R Cullen
Journal:  Nature       Date:  2008-07-02       Impact factor: 49.962

10.  Locus coeruleus to basolateral amygdala noradrenergic projections promote anxiety-like behavior.

Authors:  Jordan G McCall; Edward R Siuda; Dionnet L Bhatti; Lamley A Lawson; Zoe A McElligott; Garret D Stuber; Michael R Bruchas
Journal:  Elife       Date:  2017-07-14       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.